Results

Total Results: 2,463 records

Showing results for "testing".

141. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
     December 01, 2015 - Standard basic testing for TB costs about $40, and drug susceptibility testing can add another $102 … As for susceptibility testing, compared with conventional culture-based susceptibility testing, the … Xpert MTB/RIF point-of- care testing had similar sensitivity to laboratory-based Xpert MTB/RIF testing … Xpert MTB/RIF into a TB diagnostic algorithm, TB testing without molecular testing was calculated … When all health-system costs were considered, TB testing without molecular testing was most costly

142. Disposition of Comments Report for Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma-Cell Dyscrasias (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_disposition-comments.pdf
     August 23, 2012 - Followup testing was omitted as an intervention in the definition of KQ5, but the use of FLC, SPEP ( … The frequency of follow up testing in the various risk groups is certainly an area for more research … The IMWG criteria for progression and relapse only use SFLC testing in the absence of any other signs … Peer Reviewer #2 General Our clinical practice has incorporated FLC assays into testing for PCD. … compared to standard testing alone.

143. Comparative Effectiveness of Noninvasive Technologies for the Diagnosis of Coronary Artery Disease (CAD) in Women | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cad-women-diagnosis/research-protocol
     December 08, 2010 - with exercise ECG is the oldest and most commonly used form of stress testing. … . 3 In summary, many factors affect the accuracy of diagnostic testing for CAD in women, 3 including … . 4 After undergoing coronary angiography, some patients may be referred for noninvasive stress testing … Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease … ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College

144. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
     June 06, 2011 - with exercise ECG is the oldest and most commonly used form of stress testing. … diagnostic performance, ability to localize areas of ischemia, and the option of performing stress testing … .3 In summary, many factors affect the accuracy of diagnostic testing for CAD in women,3 including: … .4 After undergoing coronary angiography, some patients may be referred for noninvasive stress testing … ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College

145. Disposition of Comments Report for Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
     June 12, 2012 - Perhaps "NIT modality" or "testing modality" may better reflect what it is meant. … However it appears to involve statistical testing. … P-values arise from testing for presence of interactions. … Layered testing as a focus for future research must be emphasized along with appropriateness of testing … We agree and have already discussed layered testing in the Discussion section.

146. Topic Brief: Screening and Treating Non-Alcoholic Fatty Liver Disease (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/na_liver_disease_topic_brief_topic_brief.pdf
     October 30, 2020 - We did not find a specific screening and testing strategy aimed at this population. … A testing algorithm for this population has been proposed (See Figure 1). … The options for next steps might be 1) no additional testing for NAFLD; 2) additional testing for everyone … who has abnormal LFTs; and 3) additional testing for those who are “high risk” by the definition given … In any case, if additional testing were done, it would be an ultrasound, since this test was not done

147. Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
     April 01, 2020 - However, such testing is time consuming and access is limited in some clinical settings. … the biomarker testing search covered from 2012 to March 2019. … No studies examined the accuracy of blood testing. … studies and few brain imaging or CSF testing studies reported on harms. … Studies should systematically collect data on potential harms of cognitive testing.

148. Cad-Women-Diagnosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
     June 01, 2012 - In testing for a statistically significant difference between the diagnostic accuracy of testing modalities … In fact, multiple testing or layered-testing strategies are areas where significant research is needed … A comparison of a functional testing strategy to an anatomic testing strategy for patients with symptomatic … As stated previously, multiple testing or layered-testing strategies, plus the influence on risk- factor … More evidence about predictors affecting diagnostic cardiac testing is needed to support or dispel

149. Procalcitonin for Diagnosis and Management of Sepsis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/procalcitonin/research-protocol
     April 26, 2011 - Adverse events of testing, such as pain, local bleeding, or infection? … Adverse events of testing, such as persistent or recurrent infection, and antibiotic resistance? … quality of life, and/or mortality) and link G (adverse events of testing). … An early link in an indirect chain of evidence concerns the diagnostic accuracy of testing (B). … HER2 Testing to Manage Patients With Breast Cancer or Other Solid Tumors.

150. Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/musculoskeletal-complaints-tests-children/research-protocol
     September 29, 2010 - 2013 Surveillance Report Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing … The scan identified two systematic reviews examining the use of ANA testing in JIA, one focused specifically … No systematic reviews examining ANA for pediatric SLE or RF and CCP testing for JIA were identified. … Antinuclear antibody (ANA) testing. Pediatr Rev 2003;24:320-1. Syed RH, Gilliam BE, Moore TL. … Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.

151. Evidence-based Practice | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/evidence-based-practice
     September 01, 2019 - and Lessons Learned White Paper February 11, 2019 Development and Usability Testing

152. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
     April 01, 2010 - Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing … Quality-ASSIST supportive oncology quality indicator set: feasibility, reliability, and validity testing … Cancer Quality-ASSIST supportive oncology quality indicator set: feasibility, reliability, and validity testing … had both reliability and validity issues, leaving a set of 41 indicators most promising for further testing … communication are very different from those assessing discrete, concrete events like fecal occult blood testing

153. Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
     December 01, 2012 - What Important Issues are Raised by Using GEP Testing for Stage II Colon Cancer? … What Important Issues are Raised by Using GEP Testing for Stage II Colon Cancer? … • Is GEP testing a replacement or add-on technology? Guiding Question 2. … Is GEP Testing a Replacement or add-on Technology? … Adverse events of testing?

154. Lung-Cancer-About-160226 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-about-160226.pdf
     March 09, 2016 - N Field-testing was conducted with high-risk smokers who were eligible for lung cancer screening … but were not explicitly seeking screening. 23 Field-testing showed that the decision aid was acceptable … Y 24 Field-testing showed that people who were undecided felt that the information was presented … N Field-testing was conducted with high-risk smokers who were eligible for lung cancer screening … Leal, MPH Project Manager, Development and Testing Department of Health Services Research Division

155. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_june_2012.pdf
     January 01, 2012 - Such testing is intended to help women avoid unnecessary, invasive followup testing that could pose …  Key Expert Comments: Overall, experts commenting on maternal blood-based fetal DNA testing viewed … However, a negative result could help some women avoid more invasive testing. … , this fetal DNA testing platform will likely not reduce health disparities. … Overall, experts saw potential for this intervention to significantly impact testing for trisomy 21 at

156. Evaluation of Mental Health Applications | Effective Health Care Program
     effectivehealthcare.ahrq.gov/webform/products/mental-health-apps/submit-sead
     June 28, 2021 - Leave this field blank CAPTCHA This question is for testing whether or not you are a human visitor

157. Diagnosis of Celiac Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/celiac-disease/research-protocol
     June 11, 2014 - The validity and acceptability of the various diagnostic testing regimens and criteria have remained … Finally, in response to a comment about how previously negative testing affects test accuracy, we added … length of time ingesting gluten before diagnostic testing? … biopsy) or harms (related to false positives, false negatives, indeterminate results) associated with testing … FN Positive and negative likelihood ratios For KQ 1b, for clinical decision-making Additional testing

158. Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
     November 19, 2009 - This indirectness in the link between testing and its downstream effects poses practical challenges … Although testing in itself can affect outcomes directly,1 most of its impact is indirect. … Tradeoffs All testing procedures and treatment decisions are associated with benefits, risks, and … Direct effects include testing-induced emotional, cognitive, and behavioral changes or complications … Patient outcome after testing. Med Decis Making 2009;29(5):E30-E38 2.

159. Pulmonary Arterial Hypertension: Screening, Management, and Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hypertension-pulmonary-arterial/research
     April 25, 2013 - to evaluate the comparative validity, reliability, and feasibility of echocardiography and biomarker testing … accuracy and discrimination; however, one good-quality prospective cohort study suggested that biomarker testing … combination of echocardiography and the biomarker NT-proBNP is sufficiently accurate to rule out PAH when testing

160. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/health-data-mapping/protocol
     December 03, 2019 - Manufacturers of FDA regulated devices typically are required to demonstrate, through testing, that their … Direct (hands on) usability and performance testing will be restricted to those technologies that are … If there are no such technologies, then we will expand this testing to include any technologies that … Data Synthesis Direct (hands on) usability and performance testing will be restricted to those … If there are no such technologies, then we will expand this testing to include any technologies that